These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29324251)
1. Potential role of Plasmodium falciparum exported protein 1 in the chloroquine mode of action. Lisewski AM; Quiros JP; Mittal M; Putluri N; Sreekumar A; Haeggström JZ; Lichtarge O Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):31-35. PubMed ID: 29324251 [TBL] [Abstract][Full Text] [Related]
2. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs. Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182 [TBL] [Abstract][Full Text] [Related]
3. Correlation of Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism. He Z; Chen L; You J; Qin L; Chen X Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959 [TBL] [Abstract][Full Text] [Related]
5. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927 [TBL] [Abstract][Full Text] [Related]
6. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya. Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431 [TBL] [Abstract][Full Text] [Related]
7. Molecular surveillance of chloroquine drug resistance markers (Pfcrt and Pfmdr1) among imported Plasmodium falciparum malaria in Qatar. Acharya A; Bansal D; Bharti PK; Khan FY; Abusalah S; Elmalik A; ElKhalifa M; Mohapatra PK; Mahanta J; Sehgal R; Singh N; Sultan AA Pathog Glob Health; 2018 Mar; 112(2):57-62. PubMed ID: 29125042 [TBL] [Abstract][Full Text] [Related]
8. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine. Edaye S; Tazoo D; Bohle DS; Georges E Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine. Huang B; Wang Q; Deng C; Wang J; Yang T; Huang S; Su XZ; Liu Y; Pan L; Li G; Li D; Zhang H; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zheng S; Xu Q; Lu F; Guan Y; Song J Malar J; 2016 Aug; 15(1):414. PubMed ID: 27527604 [TBL] [Abstract][Full Text] [Related]
10. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277 [TBL] [Abstract][Full Text] [Related]
11. Near Infrared Fluorophore-Tagged Chloroquine in Chan LY; Teo JDW; Tan KS; Sou K; Kwan WL; Lee CK Molecules; 2018 Oct; 23(10):. PubMed ID: 30322183 [TBL] [Abstract][Full Text] [Related]
12. Sharma S; Kaitholia K; Mishra N; Srivastava B; Pillai CR; Valecha N; Anvikar AR Indian J Med Microbiol; 2016; 34(4):509-512. PubMed ID: 27934832 [TBL] [Abstract][Full Text] [Related]
13. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Sanchez CP; Stein WD; Lanzer M Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus. Li GD Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam. Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808 [TBL] [Abstract][Full Text] [Related]
16. Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen. Bamaga OA; Mahdy MA; Lim YA Acta Trop; 2015 Sep; 149():59-63. PubMed ID: 26001972 [TBL] [Abstract][Full Text] [Related]
17. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Cooper RA; Hartwig CL; Ferdig MT Acta Trop; 2005 Jun; 94(3):170-80. PubMed ID: 15866507 [TBL] [Abstract][Full Text] [Related]
18. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro. Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702 [TBL] [Abstract][Full Text] [Related]
19. Glutathione-S-transferases from chloroquine-resistant and -sensitive strains of Plasmodium falciparum: what are their differences? Rojpibulstit P; Kangsadalampai S; Ratanavalachai T; Denduangboripant J; Chavalitshewinkoon-Petmitr P Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):292-9. PubMed ID: 15691127 [TBL] [Abstract][Full Text] [Related]
20. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Biot C; Dessolin J; Grellier P; Davioud-Charvet E Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]